NY Gov Tried to Dunk on Trump About the Knicks, and Failed Miserably
Why This Milwaukee Brewers Pitcher Got a One-Game Suspension. It Was Pretty Damn...
The Cleveland Cavaliers Couldn't Admit This Simple Fact After Getting Crushed by the...
The Sign of Trouble for the James Talarico Campaign Is How the Press...
Jefferson on How to Restore the Republic
Pollsters Are Underestimating Trump 10 Years Later. What Might It Mean for the...
The Push by Democrats to Ban One of the Commonly Owned Handguns in...
How AI Threatens to Destroy the Core Self and How to Fight Back
Mission Laundering: What the OpenAI Verdict Didn't Resolve
Germany's Bureaucracy Crisis: How Red Tape Is Costing the Economy €146 Billion a...
The Real AI Risk Isn’t Regulation. It’s Strategic Blindness.
America Is Sleepwalking Toward Q-Day While Cybercriminals Prepare for the Future
Putin’s Efforts to Subvert Armenia’s Elections Can Harm US Interests
The Deal to Keep the Islamic Republic Alive
US-UAE Relations: Dubai Remains a Pillar of Stability in the Middle East
Tipsheet

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness
AP Photo/Jose Luis Magana

President Donald Trump has signed an executive order to speed the use of psychedelic drugs as a potential treatment for serious mental illness. 

The order directs the Food and Drug Administration to the Commissioner’s National Priority Vouchers to appropriate psychedelic drugs that have received breakthrough therapy designations for treating serious mental illnesses. 

Advertisement

That designation aims to ensure that people with serious mental illnesses, including veterans, can receive help. America’s veterans have a suicide rate of twice that of non-veterans. For over 20 years, there have been more than 6,000 veteran suicides per year.

The Order further directs the FDA and the Drug Enforcement Agency to establish a pathway for eligible patients to access investigational psychedelic drugs, including ibogaine compounds, that are under FDA review and that have met basic safety requirements under President Trump’s landmark Right to Try Act.

The Order requires the Secretary of Health and Human Services to allocate $50 million through the Advanced Research Projects for Health program to match investments made by state governments to advance research into psychedelic programs for populations with serious mental illness.

The HHS and FDA will collaborate with the Department of Veterans Affairs and the private sector to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies. 

The order tells the Attorney General to review these drugs upon successful completion of Phase 3 clinical trials so they can be rescheduled, if appropriate. 

Advertisement

Today, over 14 million American adults have a serious mental illness— a diagnosable mental, behavioral, or emotional disorder that substantially interferes with a person’s life and ability to function.


Advertisement



Editor’s Note: Do you enjoy Townhall’s conservative reporting that takes on the radical Left and woke media? Support our work so that we can continue to bring you the truth.

Join Townhall VIP and use promo code FIGHT to receive 60% off your membership.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos